Guggenheim Capital LLC Eagle Pharmaceuticals, Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$17.74 - $31.87 $68,831 - $123,655	-3,880 Reduced 23.28%	12,787 $248,000
Q1 2023 May 10, 2023	BUY	$25.06 - $34.09 $17,466 - $23,760	697 Added 4.36%	16,667 $472,000
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $5,620 - $8,948	225 Added 1.43%	15,970 $466,000
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $103,302 - $184,239	-3,910 Reduced 19.89%	15,745 $416,000
Q2 2022 Aug 15, 2022	BUY	$41.26 - $51.35 $79,342 - $98,746	1,923 Added 10.84%	19,655 $873,000
Q1 2022 May 16, 2022	BUY	$44.58 - $52.6 $62,501 - $73,745	1,402 Added 8.59%	17,732 $877,000
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $354,051 - $439,666	-7,727 Reduced 32.12%	16,330 $832,000
Q3 2021 Nov 15, 2021	BUY	$43.79 - $55.78 $314,674 - $400,835	7,186 Added 42.59%	24,057 $1.34 Million
Q2 2021 Aug 13, 2021	BUY	$36.86 - $44.5 $621,865 - $750,759	16,871 New	16,871 $722,000
Q3 2020 Nov 13, 2020	SELL	$37.02 - $51.28 $159,889 - $221,478	-4,319 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$43.24 - $55.02 $5.2 Million - $6.61 Million	-120,144 Reduced 96.53%	4,319 $207,000
Q1 2020 Jun 02, 2020	SELL	$34.37 - $60.07 $24,162 - $42,229	-703 Reduced 0.56%	124,463 $5.73 Million
Q4 2019 Feb 14, 2020	BUY	$54.32 - $64.31 $185,774 - $219,940	3,420 Added 2.81%	125,166 $7.52 Million
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $33,121 - $37,307	-622 Reduced 0.51%	121,746 $6.89 Million
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $4,101 - $5,143	-88 Reduced 0.07%	122,368 $6.81 Million
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $84,549 - $113,330	-2,187 Reduced 1.75%	122,456 $6.18 Million
Q4 2018 Feb 14, 2019	BUY	$36.72 - $67.73 $1.37 Million - $2.52 Million	37,174 Added 42.5%	124,643 $5.02 Million
Q3 2018 Nov 14, 2018	SELL	$66.65 - $83.86 $1.93 Million - $2.43 Million	-28,982 Reduced 24.89%	87,469 $6.06 Million
Q2 2018 Aug 14, 2018	SELL	$51.25 - $76.62 $3.81 Million - $5.69 Million	-74,254 Reduced 38.94%	116,451 $8.81 Million
Q1 2018 May 15, 2018	BUY	$52.16 - $66.86 $2.84 Million - $3.64 Million	54,509 Added 40.02%	190,705 $10 Million
Q4 2017 Feb 14, 2018	SELL	$49.6 - $60.87 $271,113 - $332,715	-5,466 Reduced 3.86%	136,196 $7.28 Million
Q3 2017 Nov 14, 2017	BUY	$46.62 - $60.36 $6.6 Million - $8.55 Million	141,662	141,662 $8.45 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account